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1. Introduction 
Inflammatory bowel diseases (IBD) constitute a group of incurable, inflammatory GI 
diseases of unknown etiology and the chronic course, with periods of spontaneous disease 
remissions and aggravations (Muszyński, 2001). This group of diseases  includes Crohn`s 
disease and ulcerative colitis. They are characterized by inflammatory reactions and changes 
in the structure of intestinal mucosa (Rzeszutko, 2006). IBD etiopathogenesis is not clearly 
defined. The most essential etiological issues include environmental factors, genetic 
conditioning, abnormalities of intestinal immunological mechanisms and the bacterial flora 
(Konturek, 2001). The inflammation which develops in the intestine is mostly due to 
improper, low-fiber diet which is based on highly processed products and on the poor 
physical activity. Familial diseases confirmed in 10% of cases speak for the genetic source. 
Immunological mechanisms which develop in response to food and bacterial antigens are 
extremely significant (Muszyński, 2001; Polińska et al., 2009). A markedly increased interest 
has  been observed in the intestinal microflora which is believed to be essential in inducing  
IBD development and in  relapses of  its clinical symptoms. Bacteria which are normally 
resident in the GI tract determine the proper work of intestines and protect  from excessive 
proliferation of undesired microorganisms. The contribution of the intestinal flora to  
the development of the biofilm, which prevents the colonization of pathogens including 
fungi of the genus Candida in the GI tract, is extremely significant. The area of interest in 
fungi which are a part of microflora and constitute a potential source of systemic 
dissemination by colonizing the GI tract has greatly increased lately (Berhardt & Knoke, 
1997). In the normal environment fungi are in balance with the bacterial flora and as 
commensals do not induce the inflammation. The main cause of its development, however, 
is the immune system impairment and a decrease of immunity. It affects patients with 
neoplasms and transplant recipients (Pfaller & Diekema, 2007; Warnock & Campbell, 1996). 
Other diseases causing inflammations are: diabetes and other endocrinopathies, infections 
due to HIV virus and also surgical procedures, damaged tissues and inflammations of the 
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mucous membrane of the alimentary tract. Aggressive therapies with antibiotics, steroids 
and immunosuppressants disturb the endogenic bacterial flora and as a result contribute to 
the development of mycoses (Budak et al., 2003; Schelenz, 2008). The most essential factors 
affecting the increase of  the frequency of fungal infections, especially those with Candida 
etiology, are   commonly used  invasive medical devices introduced  into the human body, 
such as various   catheters, tracheotomy tubes, stents, prostheses, implants and pacemakers 
which develop the biofilm on their surfaces due to fungi. The formation of the biofilm  due 
to fungi which cause the inflammation has an essential clinical effect because it increases 
their resistance to drugs as well as the ability of cells which are inside the biofilm to defend 
themselves againt the immunological reaction of the host. The biofilm formed on the surface 
of medical devices which have been introduced into the body decreases their effectiveness 
and is the source of future inflammations (Jain et al., 2007; Ramag et al., 2006). 
In the considerable number of healthy individuals fungi of the genus Candida colonize the 
oral cavity and pass through the esophagus, the stomach and the small intestine to reside in 
the large intestine. A number of healthy carriers of Candida in the oral cavity amounts to 30-
50%, where C.albicans is a predominant species, constituting 70-80%. The most frequent site 
of candidiasis is the large intestine. Erosions, extensive ulcerations covered by false 
membranes and thrush-like changes develop within the mucous membrane. The fungal 
penetration into the submucosal membrane, muscularis and blood vessels is also possible. It 
includes vascular inoculation and the formation of microabscesses in various organs and 
tissues. Vascular invasion can lead to the obstruction of the artery and eventually to 
myocardial infarction.  
Fungi of the genus Candida which are present in the large intestine were considered as 
sources of chronic and recurrent infections which can lead to the development of 
inflammations. Intestinal inflammations are likely to produce favorable conditions for the 
fungal invasion (Zwolińska-Wcisło et al., 2006). It is difficult to show the border between the 
colonization and the infection caused by fungi of the genus Candida within the oral cavity 
because asymptomatic carriers frequently develop the abundant increase of fungi in the 
cultured oral cavity and throat smears. It means that the presence of fungi on the mucous 
membrane of the oral cavity cannot be treated only as  the saprophytic flora. In the healthy 
individual the stomach and the small intestine have the function of the passage of the fungal 
flora. In patients from the risk group the initial segment of the small intestine can be the site 
of the pathological colonization of fungi and the fungal infection develops  in the ileocecal 
segment. Affected patients experience stomach cramps, flatulence, diarrhea and GI bleeding 
i.e., symptoms frequently reported by patients with acute IBD in the medical history 
(Mokrowiecka & Małecka-Panas, 2007).  
It is difficult to explain the relation between the occurrence of fungi and the development of  
inflammations because candidiasis of the oral cavity and further segments of the GI tract is 
not the frequent subject of investigations.  Recent studies on the role of fungi of the genus 
Candida in inflammatory bowel diseases were performed in the group of patients with IBD 
whose clinical samples for mycological investigations were collected by means of 
colonoscopy  (biopsy taken from the large intestine, aspirate from the intestinal contents and 
brush-smears), as well as the throat smear and the examination of feces. Samples were taken 
from patients in various periods of symptom aggravation. It was revealed that despite the 
abundant increase of fungi in throat and feces cultures no essential settlement of fungi on 
the mucous membrane of the large intestine was noted. However, while performing regular 
mycological studies of the group of patients with the history of the 5-year- course of the 
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disease fungi were isolated from all clinical samples in each acute stage of the disease. It was 
shown  that the presence of fungi in the oral cavity of this group of patients could affect the 
significantly frequent fungal colonization of the mucous membrane of the large intestine in 
the active phase of the disease. The possibility of the transmission of the fungal flora of the 
oral cavity to other segments of the GI tract was confirmed on the basis of 100% affinity of 
C.albicans strains isolated from the same patient, examined by means of the PCR-RAPD 
method (Trojanowska et al., 2010).  
In the most recent studies the diagnostics of invasive fungal inflammations includes 
molecular methods based on DNA and RNA analyses. The polymerase chain reaction (PCR) 
with its various modifications is routinely used. One of them is RAPD (Random Amplified 
Polymorphism DNA), commonly used in epidemiological investigations because of its rapid 
and simple procedure and the possibility of the simultaneous comparison of a large number 
of strains. 
Strain typing based on PCR-RAPD enables the determination of genetic affinity of 
investigated strains or their distinctiveness in the particular time. The RAPD method is 
based on the reaction of amplification using short starters with the randomized base 
sequence,  which bind to the analysed DNA in various sites, depending on the investigated 
strain. The presence or the lack of differences in the electrophoretic partition signifies the 
differentiation or compatibility of strains. It is used to perform epidemiological 
investigations which aim at determining the source of  infection and the clonal 
characterization of distinguished isolates. In addition, it is possible to watch the 
transmission of strains which cause the inflammation, or monitor the therapy. In case of the 
infection relapse the analysis of isolated strains enables to detect if it is caused by the same 
strain which can suggest the ineffective therapy or if it is due to other strains suggesting the 
recurred infection (Dzierżanowska, 2006).  
C.albicans is the most commonly isolated species from the GI tract and as the opportunistic 
flora can easily adapt itself to many sites of the body. However, as the non-pathogenic 
intestinal flora it can be replaced by rarely isolated but more virulent non-albicans strains, 
such as: C.glabrata, C.tropicalis and C.krusei. It is significant to explain if non-albicans species 
isolated from various clinical samples of the same patient can constitute one clone 
transferred from the oral cavity to the lower segments of the GI tract or if various factors 
affect the genetic diversity of isolated strains?   
2. The aim of the study 
The aim of the study was the determination of the genetic diversity of Candida spp. strains 
isolated from clinical samples of various segments of the GI tract of the same patient using 
PCR-RAPD method and the assessment of the transmission of non-albicans strains in the 
alimentary tract based on the analysis of obtained results of genetic investigations.  
3. Materials and methods 
The material for the study consisted of 39 Candida spp. strains  isolated from clinical samples 
taken by means of colonoscopy and from the oral cavity and feces of patients diagnosed in 
the Department of Gastroenterology, Hepatology and Infective Diseases of Jagiellonian 
University Collegium Medicum in Cracow. The strains came from 7 patients. In four of them 
ulcerative colitis was diagnosed and three of them developed Crohn`s disease. In six 
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patients non-albicans strains were cultured on all clinical samples and in one patient 
C.albicans strains were cultured on samples taken from the GI tract twice, at one-year-
interval. Clinical samples for mycological examinations were taken in various periods of 
symptom aggravation. The smear and feces were examined before preparing the patient for 
colonoscopy during which the biopsy was taken from the affected mucous membrane of the 
large intestine as well as the aspirate of intestinal contents and the brush-smear.The 
identification of fungi was carried out using the CAN2 chromogenic base (bioMerieux) and 
API Candida tests (bioMerieux). Genetic examinations were performed using the PCR-
RAPD technique for 10 C.albicans strains isolated from 1 patient, 20 C.glabrata strains from 4 
patients, 5 C.tropicalis strains from 1 patient and 4 C.krusei strains from 1 patient. 
3.1 DNA isolation 
From the 48-hour-culture of strains on the Sabouraud agar (bioMerieux) the suspension in 
0.85%  NaCl was compounded. Genomic DNA was isolated using Genomic Mini AX YEAST 
(A&A Biotechnology). DNA concentration was marked spectrophotometrically at the wave 
length equal to 260nm. 
3.2 PCR-RAPD reaction 
In the PCR-RAPD reaction 3 primers were used: CD16AS(5`-CTC TTG AAA CTG GGG 
AGA CTT GA-3`), ERIC2 (5`-AAG TAA GTG ACT GGG GTG AGC G-3`) and HP1247 (5`-
AAG AGC CCG T-3`). The reaction was conducted using Promega reagents. The reaction 
mixture in its final volume of 25 ul contained: 5 ul 5x colourless Go Taq Flexi Buffer (ph 8.5), 
1.5 ul 25mM MgCl2, 100 uM of each nucleotide, 100pmol primer and 0.625 U Go Taq DNA 
polymerase. The following RAPD reaction conditions were stated for the examined strains: 
initial denaturation at 94ºC for 5 min, 45 cycles comprising the true denaturation at 94ºC for 
1 min, primer attachment at 36ºC for 1 min, elongation at 72ºC for 1 min and final 
prolongation at 72ºC for 7 min. 
3.3 Electrophoresis in the agarose gel 
Reaction products were detected during electrophoresis in the 2% agarose gel (Sigma), in 
the TBE buffer (Tris-Borate Buffer) and the differentiation of the electrophoresis image of 
PCR-RAPD reaction products in the BIO-PROFIL Bio-ID++ program was analysed (Vilber-
Lormat, France).  
4. Results 
The assessment of the Candida spp. strain transmission in the GI tract was performed on the 
basis of the PCR-RAPD reaction product analysis comprising the determination of a degree 
of affinity between strains isolated from particular segments of the GI tract of the same 
patient. The examinations included strains isolated from the following clinical samples: 
throat smear (1), biopsy of the affected wall of  the large intestine (2), aspirate of intestinal 
contents (3), brush-smear from the intestine (4), feces (5). C.glabrata was isolated from 
clinical samples of 4 patients, C.tropicalis and C.krusei were isolated from other examined 
patients and C.albicans was isolated from the same patient twice, at one-year-interval. The 
selective amplification of the genetic material obtained from examined strains with CD16SA, 
ERIC2 and HP1247 primers confirmed 100% homology among C.albicans strains isolated for 
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the first time from the patient No.I (Fig.1) and C.glabrata strains from the patient No.II 
(Fig.2).  
 
 
1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 1. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.albicans strains isolated 
from patient No.I (the first isolation). 
 
 
1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 2. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.glabrata strains isolated 
from patient No.II. 
100% compatibility was also revealed with two primers (CD16AS and ERIC2) in case of 
C.glabrata from the patient No.III and the HP1247 primer showed 100% compatibility 
between strains taken from the throat, biopsy, aspirate and feces as well as 80% strain 
homology from the brush-smear (Fig.3). Similarly, 100% homology with CD16AS and ERIC2 
primers was obtained in case of C.tropicalis from the patient No.VI and over 80% homology 
with the HP1247 primer was achieved (Fig.7).  
The homology lower than 90% with three primers was found among C.albicans cultured a 
year after the first isolation from the patient No.I (Fig.5), C.glabrata derived from the patient 
No.IV (Fig.6) and the patient No.V (Fig.7) as well as C.krusei isolated from the patient No.VII 
(Fig.8).  
A degree of homology equal to or exceeding 90% was assumed as a criterium of the lack of 
genetic strain diversity (Speijer  et al., 1999) (Tab.1). 
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1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 3. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.glabrata strains isolated 
from patient No.III. 
 
 
1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 4. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.tropicalis strains isolated 
from patient No.VI. 
 
 
1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 5. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.albicans strains isolated 
from patient No.I (second isolation). 
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1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 6. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.glabrata strains isolated 
from patient No.IV. 
 
 
1- throat smear, 2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- 
feces, M- marker (100bp) 
Fig. 7. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.glabrata strains isolated 
from patient No.V. 
 
 
2- colonic biopsy, 3- aspirate of intestinal contents, 4- brush-smear from the intestine, 5- feces, M- 
marker (100bp) 
Fig. 8. Distribution of the products of PCR-RAPD reaction with three primers (CD 16 AS, 
ERIC-2, HP 1247) on agarose gel, showing similarities between C.krusei strains isolated from 
patient No.VII. 
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Patient Strain Degree of homology 
I Candida albicans >90% 
I Candida albicans <90% 
II Candida glabrata >90% 
III Candida glabrata >90% 
IV Candida glabrata <90% 
V Candida glabrata <90% 
VI Candida tropicalis >90% 
VII Candida krusei <90% 
Table 1. A degree of homology among Candida spp. strains isolated from clinical samples 
from patients with IBD. 
5. Discussion 
Results of earlier investigations performed in a group of patients with IBD confirmed the 
possibility of the oral cavity fungal flora transmission to further segments of the GI tract on 
the basis of 100% genetic affinity among isolated C.albicans strains in the PCR-RAPD method 
(Trojanowska et al., 2010). It was an impulse for performing current investigations which 
include the analysis if non-albicans strains isolated from various clinical samples, taken 
from the same patient turn out to be one clone or not and if not, which factors cause the 
genetic diversity among these strains? 
The analysis of C.albicans genotypes isolated from the patient No.I in the first examination 
of the acute stage of the disease revealed 100% homology of all strains. The passage of 
C.albicans is highly probable due to the properties of this fungal species. It is the most 
common opportunistic species having a great ability to adapt itself to various 
environments of the body, which is determined by the high expression of virulent factors 
responsible for the pathogen invasion (enzymes, phenotypic variability, adhesion) 
(Dzierżanowska, 2006). It is extremely interesting that the analysis of C.albicans strains 
isolated from the same patient after one-year-observation showed the larger variability of 
strains, especially the strain isolated from the oral cavity whose similarity to other strains 
amounted to 61-90%, depending on the used primer. The change could have been affected 
by the used therapy and in the result by the selection of the more resistant clone. This 
finding is confirmed by investigations performed by Tanaka,  which enabled to divide 
strains isolated during the course of candidiasis into three groups. One of them included 
strains which were replaced by other strains during the course of the disease (Tanaka , 
1997). In our investigations, which analysed non-albicans strains, 100% similarity was 
confirmed in C.glabrata strains isolated from  patients No.II and III as well as the patient 
No.IV (C.tropicalis), using CD16AS and ERIC2 primers while the HP1247 primer turned 
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out to be more differentiating for investigated strains. Other patients (No.IV, V, VII) 
developed the larger differentiation between strains. The attention should be focused on 
the fact that some differences in the Candida spp. strain homology can be determined by 
the limited repeatability of the PCR-RAPD method as well as its considerable 
susceptibility to changes of reaction conditions, such as: the concentration of the primer 
and other reaction constituents (Wolinowska,  2002). Moreover, slight genome mutations 
affecting the RAPD profile change may emerge during the frequent strain passage and a 
long-term culture (Lehmann et al., 1992). The patient`s condition, susceptibility to 
infection and the used therapy are also significant in the selection and differentiation of 
strains.  
Inflammatory processes which accompany the main disease are essential factors 
predisposing to the invasive growth of Candida in patients with IBD. These patients 
develop pathological factors in the structure of the GI wall, disturbed immunological 
mechanisms and a disproportion in the proper intestinal flora composition, which 
promote the excessive fungal development (Zwolińska-Wcisło et al., 2009). Patients  
from this group undergo the complex therapy including glucocorticoids and 
immunosuppressants which inhibit inflammatory reactions in intestines but suppress the 
immunity of the body leading to the spread of the fungal flora in areas which are specially 
favorable for its multiplication. 
Inflammatory bowel diseases are still the subject of many publications. It is interesting 
because of theoretical and cognitive issues in the aspect of discovering new etiopathogenetic 
mechanisms as well as practical ones concerning the use of new diagnostic and therapeutic 
methods. The knowledge of IBD mechanisms enables the more precise intervention into 
particular stages of the inflammatory process and the elaboration of methods to control the 
inflammation. It also allows to minimize adverse effects and eventually to improve the 
quality of life of patients affected by these diseases. The chronic character of IBD, periodic 
aggravations of the disease, the high activity of the inflammatory process as well as not 
always adequate response to the introduced treatment make these diseases serious clinical 
problems (Montgomery & Ekbom, 2002; Colombel et al., 2008). Variety of clinical symptoms, 
complications and systemic effects make that the differential diagnostics comprises 
numerous diseases (Grzymisławski & Kanikowska, 2010).Apart from some bacterial 
infections, other inflammatory diseases with the clinical picture resembling IBD, such as: 
tuberculosis as well as parasitic and fungal inflammations should be taken into 
consideration (Radwan et al., 2009). 
Investigations confirm (Trojanowska et al., 2010) that acute stages of these diseases reveal 
the presence of fungi in all clinical samples taken from the GI tract. As the endogenic flora 
fungi can be the cause of abnormal immunological mechanisms in IBD and in consequence 
can cause the development of systemic candidiasis (Radwan et al., 2009). The diagnostics of 
GI fungal diseases is based on imaging techniques (endoscopy), microscopic methods 
(histological preparations), and mycological, serological and genetic investigations (Biliński 
et al., 2008).The molecular analysis enables to detect the presence of genes determining 
factors of fungal virulence and genes resistant to antifungal drugs (Wolinowska,  2002). 
Nowadays, there is an increase of the number of inflammations due to C.krusei and 
C.glabrata strains resistant to fluconazole, the drug which is mostly used in the prevention of 
candidiasis in patients with IBD. 
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Fungi of the genus Candida constitute the essential etiological factors of opportunistic 
inflammations. The development of medicine and the introduction of new therapeutic 
strategies paradoxically contribute to the increase of fungal inflammations. It is mostly 
connected with an increasing number of patients with immunosuppression and disturbed 
homeostasis (Schelenz, 2008). 
6. Conclusions 
The transmission of Candida spp. strains in the GI tract, especially the most frequently 
isolated C.albicans and C.glabrata strains, is possible. Therefore, the fungi in the oral cavity of 
patients with IBD cannot be regarded exclusively as saprophytic flora, which  in the active 
phase of IBD, can multiply and disseminate to further parts of the GI tract. This fact suggests 
justifiability of using antifungal therapy, wich can provide the relief of symptoms of 
candidiasis or decrease in their intensity.  
This knowledge can be used in prophylaxis, diagnostics and in monitoring the treatment of  
GI tract candidiasis. The confirmation of candidiasis with the C.glabrata or C.krusei etiology 
requires the elimination of fluconazole which is commonly used in the prevention and the 
treatment of candidiasis. The introduced therapy which causes the selection of the more 
resistant clone can affect the  genetic diversity of strains. 
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